1. Kam PCA, Williams S, Yoong FFY. Vasopressin and terlipressin: Pharmacology and its clinical relevance. Vol. 59, Anaesthesia. 2004. p. 993–1001.

6. Holmes CL, Landry DW, Granton JT. Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology. Crit Care [Internet]. 2004;8(1):15–23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=420051&tool=pmcentrez&rendertype=abstract

7. Oh Y. Vasopressin and vasopressin receptor antagonists in heart failure. Electrolyte Blood Press. 2008;6:51–5.

8. Rotondo F, Butz H, Syro L V, Yousef GM, Di A, Lina I, et al. Arginine vasopressin ( AVP ): a review of its historical perspectives , current research and multifunctional role in the hypothalamo- hypophysial system. Pituitary. 2016;

9. Sharman A, Low J. Vasopressin and its role in critical care. Contin Educ Anaesthesia, Crit Care Pain [Internet]. 2008;8(4):134–7. Available from: https://academic.oup.com/bjaed/article-lookup/doi/10.1093/bjaceaccp/mkn021

10. Holmes C, Landry D, Granton J. Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology. Crit Care [Internet]. 2003;7(6):427. Available from: http://ccforum.biomedcentral.com/articles/10.1186/cc2337

11. Agers?? H, Larsen LS, Riis A, L??vgren U, Karlsson MO, Senderovitz T. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients. Br J Clin Pharmacol. 2004;58(4):352–8.